Loading patent…
AssigneeRuprecht-Karls-Universitaet Heidelberg
InventorsVolker CLEEVES, Stephan URBAN, Ralf KUBITZ
Estimating the term…
The present invention relates to lipopeptide-based compounds for use in the diagnosis, prevention and/or treatment of a liver disease or condition, preferably liver involved metabolic diseases, as well as in the control or modification of the cholesterol level or cholesterol uptake and, thus, diagnosis, prevention and/or treatment of a cardiovascular disease. The present invention furthermore relates to an in vitro or in vivo assay or method for testing or measuring the NTCP-mediated transport of test compound(s). The present invention furthermore relates to a method for the diagnosis, prevention and/or treatment of a liver disease or condition, comprising administering a therapeutically effective amount of a lipopeptide-based compound to a patient. The present invention furthermore relates to a method for the diagnosis, prevention and/or treatment of a cardiovascular disease.
A method for the diagnosis, prevention and/or treatment of a liver disease or condition, wherein said liver disease or condition is related to sodium taurocholate cotransporter polypeptide (NTCP)-mediated transport of compounds into hepatocytes, wherein said method comprises utilizing a lipopeptide-based compound.
A method for the diagnosis, prevention and/or treatment of a cardiovascular disease (CVD), comprising the use of a lipopeptide-based compound.
Dependencies are inferred from the claim text.